Basic Information
| RNALocate ID: | RLID:01001436 |
| RNA Symbol: | hsa-miR-101-3p |
| Localization: | Cytoplasm |
RNA Information
| RNA Name: | hsa-miR-101 |
| RNA ID: | miRBase:MIMAT0000099 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 20498841 |
| Tissue/Cell Line: | Nasopharyngeal carcinoma cells |
| Method: | Next-generation RNA sequencing |
| Description: | The expression level of all microRNAs that detected in the nuclear and cytoplasmic 18-30nt sRNA of 293T cell line. Table S5. The N/C values of all isomiRs. The isomiRs are shown only if it displayed a raw read count (non-normalized) more than 10 in at least one library. Data are collected from Table S5, S9. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001437 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001438 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001439 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001440 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001441 | Nucleus | GC cell line (MGC-803) | 29872807 |
| RLID:01001442 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:11001003 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001004 | Exosome | Renal cancer cells | 21670082 |
| RLID:11001005 | Exosome | Plasma | 23663360 |
| RLID:11001006 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001007 | Exosome | Serum | 25349172 |
| RLID:11001008 | Microvesicle | Plasma | 23077538 |
| RLID-D:11000033 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000298 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-101-3p | Diffuse large b cell lymphoma | MNDR-E-MI-02632 |
| MNDR | hsa-miR-101-3p | Rheumatic heart diseases | MNDR-E-MI-02633 |
| MNDR | hsa-miR-101-3p | Large cell neuroendocrine cancer | MNDR-E-MI-02634 |
| MNDR | hsa-miR-101-3p | Medulloblastoma | MNDR-E-MI-02635 |
| MNDR | hsa-miR-101-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-02636 |
| MNDR | hsa-miR-101-3p | Ovarian clear cell carcinoma | MNDR-E-MI-02637 |
| MNDR | hsa-miR-101-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-02638 |
| MNDR | hsa-miR-101-3p | Spinocerebellar ataxia type 1 | MNDR-E-MI-02639 |
| MNDR | hsa-miR-101-3p | Lymphoma | MNDR-E-MI-02640 |
| MNDR | hsa-miR-101-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-02641 |
| MNDR | hsa-miR-101-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-02642 |
| MNDR | hsa-miR-101-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-02643 |
| MNDR | hsa-miR-101-3p | Her2-receptor positive breast cancer | MNDR-E-MI-02644 |
| MNDR | hsa-miR-101-3p | Triple negative breast cancer | MNDR-E-MI-02645 |
| MNDR | hsa-miR-101-3p | Childhood acute lymphoblastic leukemia | MNDR-E-MI-02646 |
| MNDR | hsa-miR-101-3p | Dermatomyositis | MNDR-E-MI-02647 |
| MNDR | hsa-miR-101-3p | Prostate cancer | MNDR-E-MI-02648 |
| MNDR | hsa-miR-101-3p | Chronic lymphocytic leukemia | MNDR-E-MI-02649 |
| MNDR | hsa-miR-101-3p | Gastric cancer | MNDR-E-MI-02650 |
| MNDR | hsa-miR-101-3p | Gastric lymphoma | MNDR-E-MI-02651 |
| MNDR | hsa-miR-101-3p | Alzheimer disease | MNDR-E-MI-02652 |
| MNDR | hsa-miR-101-3p | Attention deficit hyperactivity disorder | MNDR-E-MI-02653 |
| MNDR | hsa-miR-101-3p | Intracranial aneurysm | MNDR-E-MI-02654 |
| MNDR | hsa-miR-101-3p | Urinary bladder cancer | MNDR-E-MI-02655 |
| MNDR | hsa-miR-101-3p | Esophageal carcinoma | MNDR-E-MI-02656 |
| MNDR | hsa-miR-101-3p | Heart disease | MNDR-E-MI-02657 |
| MNDR | hsa-miR-101-3p | Dysautonomia familial | MNDR-E-MI-02658 |
| MNDR | hsa-miR-101-3p | Duchenne muscular dystrophy | MNDR-E-MI-02659 |
| MNDR | hsa-miR-101-3p | Graves disease | MNDR-E-MI-02660 |
| MNDR | hsa-miR-101-3p | Malaria | MNDR-E-MI-02661 |
| MNDR | hsa-miR-101-3p | Leukemia | MNDR-E-MI-02662 |
| MNDR | hsa-miR-101-3p | Huntington disease | MNDR-E-MI-02663 |
| MNDR | hsa-miR-101-3p | Chorea | MNDR-E-MI-02664 |
| MNDR | hsa-miR-101-3p | Cardiovascular disease | MNDR-E-MI-02665 |
| MNDR | hsa-miR-101-3p | Moyamoya disease | MNDR-E-MI-02666 |
| MNDR | hsa-miR-101-3p | Lung cancer | MNDR-E-MI-02667 |
| MNDR | hsa-miR-101-3p | Down syndrome | MNDR-E-MI-02668 |
| MNDR | hsa-miR-101-3p | Parkinson disease | MNDR-E-MI-02669 |
| MNDR | hsa-miR-101-3p | Breast cancer | MNDR-E-MI-02670 |
| MNDR | hsa-miR-101-3p | Cancer | MNDR-E-MI-02671 |
| MNDR | hsa-miR-101-3p | Squamous cell carcinoma | MNDR-E-MI-02672 |
| MNDR | hsa-miR-101-3p | Pancreatic cancer | MNDR-E-MI-02673 |
| MNDR | hsa-miR-101-3p | Melanoma | MNDR-E-MI-02674 |
| MNDR | hsa-miR-101-3p | Rectum adenocarcinoma | MNDR-E-MI-02675 |
| MNDR | hsa-miR-101-3p | Hepatitis B | MNDR-E-MI-02676 |
| MNDR | hsa-miR-101-3p | Epithelial ovarian cancer | MNDR-E-MI-02677 |
| MNDR | hsa-miR-101-3p | Nephroblastoma | MNDR-E-MI-02678 |
| MNDR | hsa-miR-101-3p | Colon cancer | MNDR-E-MI-02679 |
| MNDR | hsa-miR-101-3p | Colon adenocarcinoma | MNDR-E-MI-02680 |
| MNDR | hsa-miR-101-3p | Familial ovarian cancer | MNDR-E-MI-02681 |
| MNDR | hsa-miR-101-3p | Prostate adenocarcinoma | MNDR-E-MI-02682 |
| MNDR | hsa-miR-101-3p | Kidney cancer | MNDR-E-MI-02683 |
| MNDR | hsa-miR-101-3p | Thyroid adenomas | MNDR-E-MI-02684 |
| MNDR | hsa-miR-101-3p | Carcinoma ductal breast | MNDR-E-MI-02685 |
| MNDR | hsa-miR-101-3p | Glioblastoma | MNDR-E-MI-02686 |
| MNDR | hsa-miR-101-3p | Astrocytoma | MNDR-E-MI-02687 |
| MNDR | hsa-miR-101-3p | Glioma | MNDR-E-MI-02688 |
| MNDR | hsa-miR-101-3p | Gallbladder cancer | MNDR-E-MI-02689 |
| MNDR | hsa-miR-101-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-02690 |
| MNDR | hsa-miR-101-3p | Osteosarcoma | MNDR-E-MI-02691 |
| MNDR | hsa-miR-101-3p | Liposarcoma | MNDR-E-MI-02692 |
| MNDR | hsa-miR-101-3p | Inclusion body myositis | MNDR-E-MI-02693 |
| MNDR | hsa-miR-101-3p | Meningioma | MNDR-E-MI-02694 |
| MNDR | hsa-miR-101-3p | Liver cancer | MNDR-E-MI-02695 |
| MNDR | hsa-miR-101-3p | Gastric adenocarcinoma | MNDR-E-MI-02696 |
| MNDR | hsa-miR-101-3p | Cervical squamous cell carcinoma | MNDR-E-MI-02697 |
| MNDR | hsa-miR-101-3p | Lung squamous cell carcinoma | MNDR-E-MI-02698 |
| MNDR | hsa-miR-101-3p | Non small cell lung carcinoma | MNDR-E-MI-02699 |
| MNDR | hsa-miR-101-3p | Lung adenocarcinoma | MNDR-E-MI-02700 |
| MNDR | hsa-miR-101-3p | Adrenocortical cancer | MNDR-E-MI-02701 |
| MNDR | hsa-miR-101-3p | Bladder urothelial carcinoma | MNDR-E-MI-02702 |
| MNDR | hsa-miR-101-3p | Kidney renal clear cell carcinoma | MNDR-E-MI-02703 |
| MNDR | hsa-miR-101-3p | Renal clear cell carcinoma | MNDR-E-MI-02704 |
| MNDR | hsa-miR-101-3p | Allergic rhinitis | MNDR-E-MI-02705 |
| MNDR | hsa-miR-101-3p | Large cell carcinoma | MNDR-E-MI-02706 |
| MNDR | hsa-miR-101-3p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-02707 |
| MNDR | hsa-miR-101-3p | Cholangiocarcinoma | MNDR-E-MI-02708 |
| MNDR | hsa-miR-101-3p | Esophageal cancer | MNDR-E-MI-02709 |
| MNDR | hsa-miR-101-3p | Liver cirrhosis | MNDR-E-MI-02710 |
| MNDR | hsa-miR-101-3p | Lung small cell carcinoma | MNDR-E-MI-02711 |
| MNDR | hsa-miR-101-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-02712 |
| MNDR | hsa-miR-101-3p | Testicular germ cell cancer | MNDR-E-MI-02713 |
| MNDR | hsa-miR-101-3p | Bladder transitional cell carcinoma | MNDR-E-MI-02714 |
| MNDR | hsa-miR-101-3p | Breast invasive carcinoma | MNDR-E-MI-02715 |
| MNDR | hsa-miR-101-3p | Early hepatocellular carcinoma | MNDR-E-MI-02716 |
| MNDR | hsa-miR-101-3p | Familiar ovarian carcinoma | MNDR-E-MI-02717 |
| MNDR | hsa-miR-101-3p | B-cell lymphoma | MNDR-E-MI-02718 |
| MNDR | hsa-miR-101-3p | Rheumatoid arthritis | MNDR-E-MI-02719 |
| MNDR | hsa-miR-101-3p | T-cell leukemia | MNDR-E-MI-02720 |
| MNDR | hsa-miR-101-3p | Malignant pleural mesothelioma | MNDR-E-MI-02721 |
| MNDR | hsa-miR-101-3p | Retinoblastoma | MNDR-E-MI-02722 |
| MNDR | hsa-miR-101-3p | Neuroblastoma | MNDR-E-MI-02723 |
| MNDR | hsa-miR-101-3p | Chronic myeloid leukemia | MNDR-E-MI-02724 |
| MNDR | hsa-miR-101-3p | Hodgkin lymphoma | MNDR-E-MI-02725 |
| MNDR | hsa-miR-101-3p | Burkitt lymphoma | MNDR-E-MI-02726 |
| MNDR | hsa-miR-101-3p | Crohn disease | MNDR-E-MI-02727 |
| MNDR | hsa-miR-101-3p | Neuromyelitis optica | MNDR-E-MI-02728 |
| MNDR | hsa-miR-101-3p | Skin cutaneous melanoma | MNDR-E-MI-02729 |
| MNDR | hsa-miR-101-3p | Skin melanoma | MNDR-E-MI-02730 |
| MNDR | hsa-miR-101-3p | Acute myeloid leukemia | MNDR-E-MI-02731 |
| MNDR | hsa-miR-101-3p | Colon and rectal adenocarcinoma | MNDR-E-MI-02732 |
| MNDR | hsa-miR-101-3p | Nasopharyngeal carcinoma | MNDR-E-MI-02733 |
| MNDR | hsa-miR-101-3p | Ovarian epithelial cancer | MNDR-E-MI-02734 |
| MNDR | hsa-miR-101-3p | Ependymoma | MNDR-E-MI-02735 |
| MNDR | hsa-miR-101-3p | Nasopharyngeal cancer | MNDR-E-MI-02736 |
| MNDR | hsa-miR-101-3p | Stroke lacunar | MNDR-E-MI-02737 |
| MNDR | hsa-miR-101-3p | Breast cancer her3+ negative | MNDR-E-MI-02738 |
| MNDR | hsa-miR-101-3p | High grade dysplastic nodule | MNDR-E-MI-02739 |
| MNDR | hsa-miR-101-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-02740 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCA1 | Homo sapiens | RR00022076 |
TOP